BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 31280982)

  • 1. Accuracy of clinical nodal staging and factors associated with receipt of lymph node dissection at the time of surgery for nonmetastatic renal cell carcinoma.
    Radadia KD; Rivera-Núñez Z; Kim S; Farber NJ; Sterling J; Falkiewicz M; Modi PK; Goyal S; Parikh R; Weiss RE; Kim IY; Elsamra SE; Jang TL; Singer EA
    Urol Oncol; 2019 Sep; 37(9):577.e17-577.e25. PubMed ID: 31280982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends and outcomes of lymphadenectomy for nonmetastatic renal cell carcinoma: A propensity score-weighted analysis of the National Cancer Database.
    Farber NJ; Rivera-Núñez Z; Kim S; Shinder B; Radadia K; Sterling J; Modi PK; Goyal S; Parikh R; Mayer TM; Weiss RE; Kim IY; Elsamra SE; Jang TL; Singer EA
    Urol Oncol; 2019 Jan; 37(1):26-32. PubMed ID: 30446458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radical Nephrectomy With or Without Lymph Node Dissection for Nonmetastatic Renal Cell Carcinoma: A Propensity Score-based Analysis.
    Gershman B; Thompson RH; Moreira DM; Boorjian SA; Tollefson MK; Lohse CM; Costello BA; Cheville JC; Leibovich BC
    Eur Urol; 2017 Apr; 71(4):560-567. PubMed ID: 27671144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The rationale and the role of lymph node dissection in renal cell carcinoma.
    Capitanio U; Leibovich BC
    World J Urol; 2017 Apr; 35(4):497-506. PubMed ID: 27364520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymph node dissection in renal cell carcinoma.
    Capitanio U; Becker F; Blute ML; Mulders P; Patard JJ; Russo P; Studer UE; Van Poppel H
    Eur Urol; 2011 Dec; 60(6):1212-20. PubMed ID: 21940096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Staging lymphadenectomy in renal cell carcinoma must be extended: a sensitivity curve analysis.
    Capitanio U; Suardi N; Matloob R; Abdollah F; Castiglione F; Briganti A; Carenzi C; Roscigno M; Montorsi F; Bertini R
    BJU Int; 2013 Mar; 111(3):412-8. PubMed ID: 22703190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. European temporal trends in the use of lymph node dissection in patients with renal cancer.
    Capitanio U; Stewart GD; Larcher A; Ouzaid I; Akdogan B; Roscigno M; Marszalek M; Dell'Oglio P; Salagierski M; Volpe A; Mir MC; Kriegmair M; Terrone C; Brookman-May SD; Montorsi F; Klatte T;
    Eur J Surg Oncol; 2017 Nov; 43(11):2184-2192. PubMed ID: 28801061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymph node dissection should not be dismissed in case of localized renal cell carcinoma in the presence of larger diseases.
    Dell'Oglio P; Larcher A; Muttin F; Di Trapani E; Trevisani F; Ripa F; Carenzi C; Briganti A; Salonia A; Montorsi F; Bertini R; Capitanio U
    Urol Oncol; 2017 Nov; 35(11):662.e9-662.e15. PubMed ID: 28801027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laparoscopic lymph node dissection in clinically node-negative patients undergoing laparoscopic nephrectomy for renal carcinoma.
    Chapman TN; Sharma S; Zhang S; Wong MK; Kim HL
    Urology; 2008 Feb; 71(2):287-91. PubMed ID: 18308105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The critical role of lymph node dissection in selecting high-risk nonmetastatic renal cancer candidates for adjuvant therapy after nephrectomy.
    Capogrosso P; Larcher A; Nini A; Muttin F; Cianflone F; Ripa F; Briganti A; Necchi A; Montorsi F; Salonia A; Bertini R; Capitanio U
    Urol Oncol; 2019 Apr; 37(4):293.e25-293.e30. PubMed ID: 30704958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of lymph node dissection and positive lymph nodes on cancer-specific mortality in contemporary pT
    Marchioni M; Bandini M; Pompe RS; Martel T; Tian Z; Shariat SF; Kapoor A; Cindolo L; Briganti A; Schips L; Capitanio U; Karakiewicz PI
    BJU Int; 2018 Mar; 121(3):383-392. PubMed ID: 28940649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emulating Target Clinical Trials of Radical Nephrectomy With or Without Lymph Node Dissection for Renal Cell Carcinoma.
    Bacic J; Liu T; Thompson RH; Boorjian SA; Leibovich BC; Golijanin D; Gershman B
    Urology; 2020 Jun; 140():98-106. PubMed ID: 32142726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extent of lymphadenectomy does not improve the survival of patients with renal cell carcinoma and nodal metastases: biases associated with the handling of missing data.
    Sun M; Trinh QD; Bianchi M; Hansen J; Abdollah F; Tian Z; Shariat SF; Montorsi F; Perrotte P; Karakiewicz PI
    BJU Int; 2014 Jan; 113(1):36-42. PubMed ID: 23490031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overall survival in patients with metastatic renal cell carcinoma and clinical N1 disease undergoing cytoreductive nephrectomy and lymph node dissection.
    Faiena I; Salmasi A; Lenis AT; Donin NM; Johnson DC; Bachour K; Drakaki A; Belldegrun AS; Pantuck AJ; Chamie K
    Urol Oncol; 2018 Feb; 36(2):79.e19-79.e26. PubMed ID: 29103965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreasing rates of lymph node dissection during radical nephrectomy for renal cell carcinoma.
    Kates M; Lavery HJ; Brajtbord J; Samadi D; Palese MA
    Ann Surg Oncol; 2012 Aug; 19(8):2693-9. PubMed ID: 22526899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of lymph node dissection in the management of renal cell carcinoma: a systematic review and meta-analysis.
    Bhindi B; Wallis CJD; Boorjian SA; Thompson RH; Farrell A; Kim SP; Karam JA; Capitanio U; Golijanin D; Leibovich BC; Gershman B
    BJU Int; 2018 May; 121(5):684-698. PubMed ID: 29319926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathologic Predictors of Survival During Lymph Node Dissection for Metastatic Renal-Cell Carcinoma: Results From a Multicenter Collaboration.
    Chipollini J; Abel EJ; Peyton CC; Boulware DC; Karam JA; Margulis V; Master VA; Zargar-Shoshtari K; Matin SF; Sexton WJ; Raman JD; Wood CG; Spiess PE
    Clin Genitourin Cancer; 2018 Apr; 16(2):e443-e450. PubMed ID: 29113770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment Trends and Outcomes for Patients With Lymph Node-Positive Cancer of the Penis.
    Joshi SS; Handorf E; Strauss D; Correa AF; Kutikov A; Chen DYT; Viterbo R; Greenberg RE; Uzzo RG; Smaldone MC; Geynisman DM
    JAMA Oncol; 2018 May; 4(5):643-649. PubMed ID: 29494739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional lymph node dissection in the treatment of renal cell carcinoma: is it useful in patients with no suspected adenopathy before or during surgery?
    Minervini A; Lilas L; Morelli G; Traversi C; Battaglia S; Cristofani R; Minervini R
    BJU Int; 2001 Aug; 88(3):169-72. PubMed ID: 11488722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphadenectomy for renal cell carcinoma and urothelial carcinoma of the upper urinary tract: analysis of evidence in the minimally invasive era.
    Geller R; Hemal S; Manny T
    Minerva Med; 2013 Jun; 104(3):261-72. PubMed ID: 23748280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.